Hipolin Intrinsic Value
HIPOLIN Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹16.50 | ₹13.20 - ₹19.80 | -70.0% | EPS: ₹0.04, Sector P/E: 25x |
| Book Value Method | asset | ₹66.67 | ₹60.00 - ₹73.34 | +21.2% | Book Value/Share: ₹26.67, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹60.00 | ₹54.00 - ₹66.00 | +9.1% | Revenue/Share: ₹40.00, P/S: 1.5x |
| PEG Ratio Method | growth | ₹16.50 | ₹14.85 - ₹18.15 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹16.50 | ₹14.85 - ₹18.15 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| Graham Defensive Method | conservative | ₹16.50 | ₹14.85 - ₹18.15 | -70.0% | EPS: ₹0.04, BVPS: ₹26.67 |
Want to compare with current market value? Check HIPOLIN share price latest .
Valuation Comparison Chart
HIPOLIN Intrinsic Value Analysis
What is the intrinsic value of HIPOLIN?
Based on our comprehensive analysis using 6 different valuation methods, the estimated intrinsic value of Hipolin (HIPOLIN) is ₹16.50 (median value). With the current market price of ₹55.00, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹16.50 to ₹66.67, indicating ₹16.50 - ₹66.67.
Is HIPOLIN undervalued or overvalued?
Based on our multi-method analysis, Hipolin (HIPOLIN) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Asset Turnover Ratio | 0.92x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Hipolin
Additional stock information and data for HIPOLIN
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-3 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |